Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001047469-13-000358
Filing Date
2013-01-22
Accepted
2013-01-22 16:08:07
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B3 a2212524z424b3.htm 424B3 4992179
2 G1044668.JPG g1044668.jpg GRAPHIC 9445
3 G892758.JPG g892758.jpg GRAPHIC 12752
4 G852386.JPG g852386.jpg GRAPHIC 5344
5 G1045333.JPG g1045333.jpg GRAPHIC 3991
6 G599590.JPG g599590.jpg GRAPHIC 4617
7 G817006.JPG g817006.jpg GRAPHIC 15690
8 G557696.JPG g557696.jpg GRAPHIC 6086
9 G688867.JPG g688867.jpg GRAPHIC 56905
  Complete submission text file 0001047469-13-000358.txt   5152594
Mailing Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-185391 | Film No.: 13540412
SIC: 2836 Biological Products, (No Diagnostic Substances)